Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmaceuticals topic
No spam. Unsubscribe anytime.
President says ‘trumprx.gov’ and agreements drove steep prescription-price cuts
Summary
President announced additions to a government drug-pricing site and credited international agreements with large reductions in U.S. prescription prices, saying nearly 1,000 low-cost generics were added to trumprx.gov.
President described a government initiative he referenced as trumprx.gov and said it and international pricing agreements have driven down U.S. prescription costs.
He said the administration recently added "nearly 1,000 low cost generics" to the site and touted "record setting discounts on prescription drugs," comparing U.S. list prices to lower prices in places such as Germany and London. "We're delivering record setting discounts on prescription drugs," the president said, and pointed party and public attention to the website as evidence that Americans can purchase medications for a fraction of prior costs.
The president framed the reductions as the result of negotiated most-favored-nation style arrangements with drug companies and trading partners; he offered an illustrative example of a medicine that sells for $10 abroad that previously cost $130 in the U.S. without asserting a single independent verification of every price point. Officials did not present a consolidated, independently sourced table of nationwide savings during the meeting, and staff said some percentage figures could be presented in several ways depending on definitions.
Cabinet members at the meeting reiterated support for the changes while noting coverage and methodology questions persist; reporters asked follow-up questions about methodology and oversaw the administration’s claim that these changes would influence midterm politics.
